`
`33845
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`
`
`
`
`GENENTECH, INC.,
`Plaintiffs,
`
`v.
`AMGEN INC.,
`
`Case No. 1:18-cv-00924-CFC
`
`Defendant and
`Counterclaim Plaintiff.
`
`
`
`
`DEFENDANT AMGEN INC.’S NOTICE OF DEPOSITION OF
`GINA CHAPMAN
`
`
`
`
`
`PLEASE TAKE NOTICE that, pursuant to Rule 30(b)(1) of the Federal Rules of Civil
`
`
`
`Procedure, counsel for Defendant Amgen Inc. (“Defendant”) will take the deposition by oral
`
`examination of Gina Chapman.
`
`PLEASE TAKE FURTHER NOTICE that the deposition will take place at the office of
`
`WilmerHale, 950 Page Mill Road, Palo Alto, CA 94304, beginning on Friday, January 24, 2020
`
`at 9:00 a.m. and continuing on consecutive business days as necessary, or at such other time and
`
`location as agreed upon by the parties. The testimony will be before a duly certified court reporter
`
`and notary public or other person authorized by law to administer oaths. The deposition will be
`
`recorded by stenographic means and by videotape.
`
`
`
`
`
`
`
`
`
`1
`
`DEFENDANT AMGEN’S
`NOTICE OF DEPOSITION
` 1:18-CV-00924
`
`
`
`Case 1:18-cv-00924-CFC-SRF Document 485 Filed 01/22/20 Page 2 of 2 PageID #:
`33846
`
`SMITH, KATZENSTEIN & JENKINS,
`LLP
`/s/ Eve H. Ormerod
`Neal C. Belgam (No. 2721)
`Eve H. Ormerod (No. 5369)
`1000 West Street, Suite 1501
`Wilmington, DE 19801
`(302) 652-8400
`nbelgam@skjlaw.com
`eormerod@skjlaw.com
`Attorneys for Defendant Amgen Inc.
`
`Dated: January 22, 2020
`Of Counsel:
`Michelle Rhyu
`Daniel Knauss
`Susan Krumplitsch
`Cooley LLP
`3175 Hanover Street
`Palo Alto, CA 94304-1130
`P (650) 843-5000
`rhyums@cooley.com
`dknauss@cooley.com
`skrumplitsch@cooley.com
`Orion Armon
`Cooley LLP
`380 Interlocken Crescent, Suite 900
`Broomfield, CO 80021-8023
`P (720) 566-4000
`oarmon@cooley.com
`Eamonn Gardner
`Cooley LLP
`4401 Eastgate Mall
`San Diego, CA 92121-1909
`P (858) 550-6000
`egardner@cooley.com
`Nancy Gettel
`Amgen Inc.
`One Amgen Center Drive
`Thousand Oaks, CA 91320-1799
`P (805) 447-1000
`ngettel@amgen.com
`
`2
`
`DEFENDANT AMGEN’S
`NOTICE OF DEPOSITION
` 1:18-CV-00924
`
`